Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Moodys
AstraZeneca
McKesson
Colorcon

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMPHETAMINE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Amphetamine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000305 Amphetamine Cocaine Interaction Study - 2 Terminated National Institute on Drug Abuse (NIDA) Phase 1 1969-12-31 The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000305 Amphetamine Cocaine Interaction Study - 2 Terminated University of Texas Phase 1 1969-12-31 The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000305 Amphetamine Cocaine Interaction Study - 2 Terminated The University of Texas Health Science Center, Houston Phase 1 1969-12-31 The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000308 Dextroamphetamine-Cocaine Behavioral Intervention - 5 Completed University of Texas Phase 2 1995-09-01 The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Amphetamine

Condition Name

Condition Name for Amphetamine
Intervention Trials
Attention Deficit Hyperactivity Disorder 12
Healthy 11
Cocaine-Related Disorders 9
Cocaine Dependence 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Amphetamine
Intervention Trials
Attention Deficit Disorder with Hyperactivity 34
Disease 27
Hyperkinesis 25
Cocaine-Related Disorders 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Amphetamine

Trials by Country

Trials by Country for Amphetamine
Location Trials
United States 110
Germany 12
Canada 9
France 6
Switzerland 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Amphetamine
Location Trials
California 14
Texas 14
New York 12
Florida 8
Maryland 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Amphetamine

Clinical Trial Phase

Clinical Trial Phase for Amphetamine
Clinical Trial Phase Trials
Phase 4 31
Phase 3 16
Phase 2/Phase 3 8
[disabled in preview] 33
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Amphetamine
Clinical Trial Phase Trials
Completed 84
Recruiting 23
Not yet recruiting 17
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Amphetamine

Sponsor Name

Sponsor Name for Amphetamine
Sponsor Trials
National Institute on Drug Abuse (NIDA) 24
Shire 11
Yale University 9
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Amphetamine
Sponsor Trials
Other 154
Industry 39
NIH 36
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Harvard Business School
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.